期刊文献+

新城疫病毒HN基因真核表达质粒的构建及其抗肿瘤作用的初步研究 被引量:10

Construction of Newcastle disease virus hemagglutinin-neuraminidase (HN) gene and its antitumor immune response effects
下载PDF
导出
摘要 目的 :构建新城疫病毒 (NDV )血凝素神经氨酸酶 (HN)基因真核表达质粒 ,并初步探索其在抗肿瘤治疗中的机制及应用价值。方法 :用 RT- PCR从 NDV中克隆 HN c DNA,并构建 HN的真核表达载体 ,转染 COS- 7细胞表达。注射至小鼠B16黑素瘤模型 ,检测其抗肿瘤作用。结果 :成功地克隆了 NDV HN c DNA,所构建的 pc DNA3- HN有良好的表达 ,动物实验显示 ,pc DNA3- HN有增强荷瘤小鼠 CTL ,NK杀伤活性的作用。结论 :NDV HN的真核表达质粒具有增强荷瘤小鼠抗肿瘤CTL ,NK细胞反应的作用。 Objective: To construct an eukaryotic expression plasmid containing gene coding for the hemagglutinin neuraminidase(HN) of Newcastle disease virus (NDV), and to study its mechanism and value in antitumor therapy. Methods: The HN cDNA was abtained from NDV with RT PCR and an eukaryotic expression vector of HN gene ( pcDNA3 HN ) was constructed. The antitumor effect was evaluated after injecting pcDNA3 HN into mice bearing B16 melanoma. Results: The HN cDNA of NDV was successfully cloned and pcDNA3 HN had a good expression in COS 7 cells. Animal experiments suggested that the pcDNA3 HN could significantly increase CTL and NK activity of tumor bearing mice. Conclusion:The eukaryotic expression plasmid containing the gene coding for the (HN) has the function of increasing CTL and NK activity of tumor bearing mice.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2000年第6期515-518,共4页 Academic Journal of Second Military Medical University
基金 国家863计划资助!项目 (10 1-0 6 -0 5 0 4)
关键词 新城疫病毒 抗肿瘤作用 HN基因 真核表达质粒 Newcastle disease virus hemagglutinins viral neuraminidase function of antitumor
  • 相关文献

参考文献9

  • 1Schirrmacher V,Haas C,Bonifer R,et al.Human tumor cell modification by virus infection: an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus[].Gene Therapy.1999
  • 2Ockert D,Schirrmacher V,Beck N,et al.Newcastle disease virusinfected intact autologous tumor cell vaccine for adjuvant active specific immunotherapy of resected colorectal carcinoma[].Clinical Cancer Research.1996
  • 3Mobus V,Horm S,Stock M,et al.Tumor cell vaccination for gynecological tumors[].Hybridoma.1993
  • 4Csatary I K,Eckhardt S,Bukoza I.Attenuated veterinary vaccine for the treatment of cancer[].Cancer Detection and Prevention.1993
  • 5Schirrmacher V,Haas C,Bonifer R,et al.Virus potentiation of tumor vaccine T-cell stimulatory capacity requires cell surface binding but not infection[].Clinical Cancer Research.1997
  • 6von,Hoegen,P,Zawatzky,R,Schirrmacher,V.Modification of tumor cells by a low dose of Newcastle disease virus: III. Potentiation of tumor specific cytolytic T cell reactivity via induction of interferon α, β[].Cellular Immunology.1990
  • 7Bohle W,Schlag P,Liebrich W,et al.Postoperative active specific immunization in colorectal cancer patients with virus-modified autologous tumor-cell vaccine[].Cancer.1990
  • 8Fleischmann W R Jr,Kleyn KM,Baron S.Potentiation of antitumor effect of virus-induced interferon by mouse immune interferon preparations[].Journal of the National Cancer Institute.1980
  • 9Plaksin D,Porgador A,Vadai E,et al.Effective antimetastatic melanoma vaccination with tumor cells transfected with MHC genes and/or infected with New castle disease virus (NDV)[].International Journal of Cancer.1994

同被引文献88

引证文献10

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部